l carnitine intramuscular or subcutaneous Injections l carnitine injection where to

the therapeutic agent is selected from an siRNA, a microRNA, an antisense oligonucleotide, and a plasmid capable of expressing an siRNA, a microRNA, or an antisense oligonucleotide the siRNA, microRNA, or antisense RNA comprises a polynucleo the present invention includes a method of treating a disease or disorder characterized by underexpression of a polypeptide in a subject, comprising providing to the subject the pharmaceutical composition of the present invention, wherein the therapeutic agent is a plasmid that encodes the polypeptide or a functional variant or fragment thereof

In this paradox, chronic and excessive doses of vitamin B6 have been shown to cause neuropathy in the hands and feet, unsteady gait, light sensitivity, skin rashes and lesions, nausea, heartburn, ataxia (loss of control of body movements), and impaired reflexes

Foda AM, Ibrahim SS, Ibrahim SM, Elbaz EM

Moreover, a study comparing TgAb- or TPOAb-positive patients with healthy controls revealed a higher frequency of hemoglobin, iron, or vitamin B12 deficiency among patients [137], highlighting the need for further investigation into the risk of vitamin B12 deficiency in HTs patients

Discussion We demonstrated that the observed inability of 6-day-old seedlings to tolerate the identical water deficit compared to 4-day-old seedlings is associated with a disturbance in cellular redox homeostasis and the reduced and oxidized ascorbate and glutathione pools